上皮成長因子受容体(EGFR)阻害剤の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3728)
◆英語タイトル:Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3728
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:96
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、上皮成長因子受容体(EGFR)阻害剤の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(肺がん、大腸がん、乳がん、その他)、用途別市場規模(病院、研究所、研究機関、診療所、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・上皮成長因子受容体(EGFR)阻害剤の市場動向
・企業の競争状況、市場シェア
・上皮成長因子受容体(EGFR)阻害剤の種類別市場規模(肺がん、大腸がん、乳がん、その他)
・上皮成長因子受容体(EGFR)阻害剤の用途別市場規模(病院、研究所、研究機関、診療所、その他)
・上皮成長因子受容体(EGFR)阻害剤の北米市場規模2016-2027(アメリカ、カナダ)
・上皮成長因子受容体(EGFR)阻害剤の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・上皮成長因子受容体(EGFR)阻害剤のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・上皮成長因子受容体(EGFR)阻害剤の中南米市場規模2016-2027(メキシコ、ブラジル)
・上皮成長因子受容体(EGFR)阻害剤の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Amgen Inc.、AstraZeneca Plc、Eli Lilly and Co.、F. Hoffmann-La Roche Ltd.、Novartis AG)
・結論
【レポートの概要】

The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands.
The high efficacy of EGFR inhibitors in the treatment of various types of cancer indications has encouraged researchers to study its use in the treatment of inflammatory and monogenic diseases. Recent in-vitro research studies have suggested that EGFR mutations may cause indications such as eczema, psoriasis, and atherosclerosis. Although these studies are in the early stages of clinical trials, the huge unmet need and further advancements in research are expected to brighten the growth prospects of EGFR inhibitors market vendors in new research areas.

Market Analysis and Insights: Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
The global Epidermal Growth Factor Receptor (EGFR) Inhibitor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market.

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Scope and Market Size
Epidermal Growth Factor Receptor (EGFR) Inhibitor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Lung Cancer
Colorectal Cancer
Breast Cancer
Others

Segment by Application
Hospital
Research Institutes and Research Institutions
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen Inc.
AstraZeneca Plc
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Novartis AG

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Lung Cancer
1.2.3 Colorectal Cancer
1.2.4 Breast Cancer
1.2.5 Others
1.3 Market by Application
1.3.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research Institutes and Research Institutions
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Perspective (2016-2027)
2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Growth Trends by Regions
2.2.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Share by Regions (2016-2021)
2.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Regions (2022-2027)
2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Dynamic
2.3.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Trends
2.3.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Drivers
2.3.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Challenges
2.3.4 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Revenue
3.1.1 Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Revenue (2016-2021)
3.1.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Players (2016-2021)
3.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue
3.4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Concentration Ratio
3.4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in 2020
3.5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players Head office and Area Served
3.6 Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Solution and Service
3.7 Date of Enter into Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Epidermal Growth Factor Receptor (EGFR) Inhibitor Breakdown Data by Type
4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Size by Type (2016-2021)
4.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Type (2022-2027)

5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Breakdown Data by Application
5.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Size by Application (2016-2021)
5.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2016-2027)
6.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
6.2.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021)
6.2.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027)
6.2.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2027)
6.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
6.3.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021)
6.3.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027)
6.3.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2027)
6.4 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
6.4.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021)
6.4.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2016-2027)
7.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
7.2.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021)
7.2.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027)
7.2.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2027)
7.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
7.3.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021)
7.3.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027)
7.3.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2027)
7.4 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
7.4.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021)
7.4.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2016-2027)
8.2 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
8.2.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2027)
8.3 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
8.3.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2027)
8.4 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region
8.4.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2016-2027)
9.2 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
9.2.1 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021)
9.2.2 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027)
9.2.3 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2027)
9.3 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
9.3.1 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021)
9.3.2 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027)
9.3.3 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2027)
9.4 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
9.4.1 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021)
9.4.2 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2016-2027)
10.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
10.2.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2016-2027)
10.3 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
10.3.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2016-2027)
10.4 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
10.4.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Details
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
11.1.4 Amgen Inc. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
11.1.5 Amgen Inc. Recent Development
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Details
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
11.2.4 AstraZeneca Plc Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
11.2.5 AstraZeneca Plc Recent Development
11.3 Eli Lilly and Co.
11.3.1 Eli Lilly and Co. Company Details
11.3.2 Eli Lilly and Co. Business Overview
11.3.3 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
11.3.4 Eli Lilly and Co. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
11.3.5 Eli Lilly and Co. Recent Development
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Company Details
11.4.2 F. Hoffmann-La Roche Ltd. Business Overview
11.4.3 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
11.4.4 F. Hoffmann-La Roche Ltd. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
11.4.5 F. Hoffmann-La Roche Ltd. Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
11.5.4 Novartis AG Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2016-2021)
11.5.5 Novartis AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 上皮成長因子受容体(EGFR)阻害剤の世界市場規模・現状・予測2021年-2027年(Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。